Differential regulation of specific genes in MCF-7 and the ICI 182780-resistant cell line MCF-7/182R-6. (Q36618242)

15 August 2017

Differential regulation of specific genes in MCF-7 and the ICI 182780-resistant cell line MCF-7/182R-6. (English)

1 reference

15 August 2017

0 references

B L Jensen

1

1 reference

15 August 2017

J Skouv

series ordinal

2

1 reference

15 August 2017

B K Lundholt

series ordinal

3

1 reference

15 August 2017

A E Lykkesfeldt

series ordinal

4

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

79

1 reference

15 August 2017

3-4

1 reference

15 August 2017

386-392

1 reference

describes a project that uses

15 August 2017

MCF-7/182R-6

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690061

0 references

cites work

Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

Are breast tumours resistant to tamoxifen also resistant to pure antioestrogens?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

The human estrogen receptor has two independent nonacidic transcriptional activation functions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

Tamoxifen in advanced breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

Differential expression of estrogen receptor mRNA splice variants in the tamoxifen resistant human breast cancer cell line, MCF-7/TAMR-1 compared to the parental MCF-7 cell line

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

Antiestrogen resistance: mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

A potent specific pure antiestrogen with clinical potential

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362436

Nuclear mechanisms of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing

20 September 2018

1 reference

12 December 2020

Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression

1 reference

12 December 2020

Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780

1 reference

12 December 2020

Acquired estrogen independence and antiestrogen resistance in breast cancer: estrogen receptor driven phenotypes?

1 reference

12 December 2020

Regulation of the estrogen receptor in MCF-7 cells by estradiol

1 reference

12 December 2020

Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells

1 reference

12 December 2020

The value of estrogen and progesterone receptors in the treatment of breast cancer

1 reference

12 December 2020

Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Dco and MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690061

7 January 2021

Expression of estrogen receptor and its messenger ribonucleic acid in the MCF-7 cell line: multiparametric analysis of its processing and regulation by estrogen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690061

7 January 2021

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690061

7 January 2021

Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690061

7 January 2021

Oestrogen receptor: a stable phenotype in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690061

7 January 2021

Identifiers

DOI

10.1038/SJ.BJC.6690061

1 reference

15 August 2017

1 reference

15 August 2017

1 reference